Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.
- DOI
- 10.1097/qai.0000000000001503
- Published
- 2017 Nov 1
- Container
- Journal of acquired immune deficiency syndromes (1999)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1097/qai.0000000000001503,
title = {Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.},
author = {Husnik MJ and Brown ER and Marzinke M and Livant E and Palanee-Phillips T and Hendrix CW and Matovu Kiweewa F and Nair G and Soto-Torres LE and Schwartz K and Hillier SL and Baeten JM and MTN-020 ASPIRE Study Team},
year = {2017},
journal = {Journal of acquired immune deficiency syndromes (1999)},
doi = {10.1097/qai.0000000000001503},
url = {https://doi.org/10.1097/qai.0000000000001503}
}RIS
TY - JOUR TI - Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial. AU - Husnik MJ AU - Brown ER AU - Marzinke M AU - Livant E AU - Palanee-Phillips T AU - Hendrix CW AU - Matovu Kiweewa F AU - Nair G AU - Soto-Torres LE AU - Schwartz K AU - Hillier SL AU - Baeten JM AU - MTN-020 ASPIRE Study Team PY - 2017 JO - Journal of acquired immune deficiency syndromes (1999) DO - 10.1097/qai.0000000000001503 UR - https://doi.org/10.1097/qai.0000000000001503 ER -
APA
MJ, H., ER, B., M, M., E, L., T, P., CW, H., F, M. K., G, N., LE, S., K, S., SL, H., JM, B., & Team, M. A. S. (2017). Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). https://doi.org/10.1097/qai.0000000000001503
Source records
- pubmed · retrieved 2026-09-27T12:10:31.064Z
- europe-pmc · retrieved 2026-09-27T12:10:31.082Z